Dermata Therapeutics Inc

Research Dermata Therapeutics Inc (DRMA) on Bullrun: market cap USD 5.23M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerDRMA
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 5.23M
• Financial periodFY2025
• Net income-USD 7.56M

Valuation Snapshot

latest market cap is USD 5.23M.

About Dermata Therapeutics Inc

Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Frequently asked questions

What is Dermata Therapeutics Inc's market cap?

Dermata Therapeutics Inc's market capitalization is USD 5.23M.

What does Dermata Therapeutics Inc do?

Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States.